An Automated Assist in Revenue Cycle Management
How automation, artificial intelligence, and other emerging technologies are elevating the efficiency and output of labs’ revenue cycles
How automation, artificial intelligence, and other emerging technologies are elevating the efficiency and output of labs’ revenue cycles
Direct-to-consumer (DTC) genetic testing has risen in popularity in recent years—but is it all it’s cracked up to be?
How virtual reality technologies can support clinical laboratory education efforts and what leaders should know about implementation
How artificial intelligence models can help labs, clinicians, and patients communicate with one another more effectively
Seven months into the year, there were already four reported deals valued at over $1 billion in 2023, as many as in all of 2022.
Proposed rule would require businesses to undergo even more stringent review to secure regulatory approval for such deals.
Diagnostics companies that invested heavily in COVID-19 products are relying on M&A transactions to restructure and transition.
In the first half of this year, US companies have cut the second-highest total of jobs since 2009, according to a recent report.
The outlook of the global genetic testing market based on recent reports from five financial consulting firms.
After an eventful month in the Illumina-GRAIL saga, the story may soon be over.
After a significant lull, M&As in the lab diagnostics space heated up in May, with several key deals announced.